We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.21%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$83.6B
AUM Growth
+$7.15B
(+9.4%)
Cap. Flow
-$1.82B
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
25.12%
Holding
2,346
New
140
Increased
813
Reduced
968
Closed
362
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$562M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$417M |
| 3 |
Apple
AAPL
|
+$182M |
| 4 |
Mastercard
MA
|
+$176M |
| 5 |
AMRZ
Amrize Ltd
AMRZ
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$864M |
| 2 |
JPMorgan Chase
JPM
|
+$322M |
| 3 |
Amazon
AMZN
|
+$190M |
| 4 |
UnitedHealth
UNH
|
+$181M |
| 5 |
Tesla
TSLA
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.19% |
| 2 | Healthcare | 9.29% |
| 3 | Financials | 9.12% |
| 4 | Energy | 9.06% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
Edwards Lifesciences
EW
$53.4B
| $931K | ﹤0.01% |
11,900
-15,000
| -56% | -$1.12M |
|
|
SEM
1677
DELISTED
Select Medical
SEM
| $929K | ﹤0.01% |
61,200
+3,468
| +6% | +$54.1K |
|
1678
PUT
Target
TGT
$70.6B
| $927K | ﹤0.01% |
9,400
-14,500
| -61% | -$1.39M |
|
1679
Adaptive Biotechnologies
ADPT
$3.89B
| $924K | ﹤0.01% |
79,300
+66,500
| +520% | +$604K |
|
1680
PUT
MSCI
MSCI
$41.8B
| $923K | ﹤0.01% |
1,600
-1,000
| -38% | -$553K |
|
|
VNET
1681
VNET Group
VNET
$2.12B
| $913K | ﹤0.01% |
132,356
-480,448
| -78% | -$2.88M |
|
1682
PUT
Idexx Laboratories
IDXX
$44.7B
| $912K | ﹤0.01% |
1,700
-1,800
| -51% | -$861K |
|
1683
ADMA Biologics
ADMA
$2.11B
| $911K | ﹤0.01% |
50,000
+33,894
| +210% | +$691K |
|
1684
Community Health Systems
CYH
$419M
| $909K | ﹤0.01% |
+267,222
| New | +$859K |
|
1685
CALL
Copart
CPRT
$27.2B
| $908K | ﹤0.01% |
18,500
-13,900
| -43% | -$778K |
|
|
AKRO
1686
DELISTED
Akero Therapeutics
AKRO
| $907K | ﹤0.01% |
17,000
+4,200
| +33% | +$191K |
|
1687
CALL
Roper Technologies
ROP
$39.3B
| $907K | ﹤0.01% |
1,600
+400
| +33% | +$226K |
|
1688
Markel Group
MKL
$22.8B
| $899K | ﹤0.01% |
450
-780
| -63% | -$1.46M |
|
1689
L3Harris
LHX
$53.7B
| $899K | ﹤0.01% |
3,583
+61
| +2% | +$14K |
|
1690
Dollar Tree
DLTR
$24.9B
| $892K | ﹤0.01% |
9,010
-13,148
| -59% | -$1.13M |
|
1691
B&G Foods
BGS
$299M
| $889K | ﹤0.01% |
+210,240
| New | +$1.1M |
|
1692
Axcelis
ACLS
$4.42B
| $887K | ﹤0.01% |
12,730
-1,800
| -12% | -$103K |
|
1693
Avantor
AVTR
$9.37B
| $882K | ﹤0.01% |
65,513
+19,813
| +43% | +$271K |
|
1694
Pediatrix Medical
MD
$2.14B
| $881K | ﹤0.01% |
61,412
+37,712
| +159% | +$517K |
|
1695
PUT
Becton Dickinson
BDX
$49.6B
| $878K | ﹤0.01% |
5,100
-2,300
| -31% | -$422K |
|
1696
Estee Lauder
EL
$31.6B
| $873K | ﹤0.01% |
10,804
-290,938
| -96% | -$18.7M |
|
1697
Innovative Industrial Properties
IIPR
$1.67B
| $864K | ﹤0.01% |
15,655
-1,855
| -11% | -$102K |
|
1698
International Money Express
IMXI
$353M
| $859K | ﹤0.01% |
85,161
-23,300
| -21% | -$266K |
|
1699
Clover Health Investments
CLOV
$2.38B
| $858K | ﹤0.01% |
+307,540
| New | +$1.01M |
|
1700
CALL
Nucor
NUE
$61.8B
| $855K | ﹤0.01% |
6,600
-8,500
| -56% | -$993K |
|
Similar funds
Allianz Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Allianz Asset Management held 2,346 positions worth $83.6B, up 9.4% from $76.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Allianz Asset Management's Q2 2025 filing shows 140 new, 813 increased, 968 reduced and 362 closed positions. Its largest new stake was Amrize Ltd: 3,188,111 shares worth $159M. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $864M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Allianz Asset Management's largest Q2 2025 buy was Amrize Ltd: 3,188,111 shares worth $159M.
- Allianz Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $562M increase.
- Allianz Asset Management's biggest Q2 2025 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $864M.
- Allianz Asset Management fully exited Discover Financial Services in Q2 2025, selling an estimated $66.5M.
- Allianz Asset Management's ten largest holdings make up 25% of its $83.6B portfolio in Q2 2025.
- Allianz Asset Management opened 140 new positions and closed 362 in Q2 2025.
- Allianz Asset Management's portfolio value rose 9.4% quarter-over-quarter to $83.6B.
Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.